Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergic rhinitis: recent advances.

F E Simons1

  • 1Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

Pediatric Clinics of North America
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of antihistamines in the new millennium.

Postgraduate medicine·2009
Same author

Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?

The Journal of allergy and clinical immunology·2001
Same author

Socioeconomic status, drug insurance benefits, and new prescriptions for inhaled corticosteroids in schoolchildren with asthma.

Archives of pediatrics & adolescent medicine·2001
Same author

Expression, purification, characterization and clinical relevance of rAed a 1--a 68-kDa recombinant mosquito Aedes aegypti salivary allergen.

International immunology·2001
Same author

Epinephrine absorption in adults: intramuscular versus subcutaneous injection.

The Journal of allergy and clinical immunology·2001
Same author

Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2001
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

New research tools enhance understanding of allergic rhinitis pathophysiology. Advances in pharmacologic treatments and immunotherapy offer improved patient care and safer allergen modifications.

Area of Science:

  • Allergy and Immunology
  • Otorhinolaryngology
  • Pharmacology

Background:

  • Allergic rhinitis pathophysiology understanding is evolving.
  • Significant advancements have been made in treatment options.
  • Research tools are crucial for investigating this common disorder.

Purpose of the Study:

  • To review recent advancements in allergic rhinitis research and treatment.
  • To highlight the impact of new research tools on understanding the disorder.
  • To discuss the evolving landscape of pharmacologic and immunotherapeutic interventions.

Main Methods:

  • Review of current literature on allergic rhinitis.
  • Analysis of new research methodologies for patient investigation.
  • Evaluation of novel pharmacologic agents and immunotherapy approaches.

Related Experiment Videos

Main Results:

  • Development of novel research tools aids in understanding disease mechanisms.
  • Introduction of non-sedating H1-receptor antagonists and topical glucocorticosteroids has improved treatment efficacy and safety.
  • Immunotherapy is evolving with stricter patient selection and development of modified allergens.

Conclusions:

  • Continued research and development are improving allergic rhinitis management.
  • Safer and more effective treatments are becoming available for patients.
  • Modified allergens represent a significant future advance in immunotherapy.